Market Place
Sourcing Support
All News #Library
FDA Issues Form 483 to Revance Therapeutics
18 Aug 2022 //
FDA
FDA Issues Form 483 to Revance Therapeutics
10 Dec 2021 //
FDA
FDA Issues Form 483 to Revance Therapeutics,
10 Dec 2021 //
FDA
FDA Issues SEIR to Revance Therapeutic, Inc.
18 Nov 2021 //
FDA
FDA Issues Form 483 to Revance Therapeutics, Inc.
12 Oct 2021 //
FDA
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.